Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Vásová

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Vnitrni Lekarstvi|October 1, 1995
[Biological effects of allogenic leukocytes and leukocyte-depleted blood cell products]I Vásová, J Mayer
Acta Medica Austriaca|January 1, 1996
New approaches to management of multiple myelomaR Hájek, I Vásová, Z Adam, et al.
Vnitrni Lekarstvi|June 1, 1995
[Infections in patients with central venous systems for long-term venous access: pathogenesis, classification, diagnosis and therapy]R Hájek, D Burgetová, I Vásová, et al.
Acta Medica Austriaca|January 1, 1996
Evolution of multiple myeloma treatment from melphalan monotherapy to bone marrow transplantationR Hájek, Z Adam, I Vásová, et al.
Bone Marrow Transplantation|April 1, 1999
Ifosfamide and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphomaJ Mayer, Z Korístek, I Vásová, et al.
Vnitrni Lekarstvi|January 1, 1997
[A new purine analog in the treatment of hematologic malignancy. I. Fludarabine]I Vásová, M Penka, R Hájek, et al.
Vnitrni Lekarstvi|April 1, 1996
[Evaluation of the cardioprotective effect of bispiperazinedione ICRF-187 (Cardioxane) in patients treated with anthracyclines--an echocardiographic study]L Elbl, I Vásová, V Chaloupka, et al.
Vnitrni Lekarstvi|April 1, 1996
[Treatment of multiple myeloma--melphalan monotherapy after bone marrow transplantation]R Hájek, Z Adam, M Krejcí, et al.
Vnitrni Lekarstvi|November 21, 2007
[Chronic fatigue syndrome in cancer patients. Diagnostic and treatment options]F Jedlicka, L Elbl, I Vásová, et al.
Vnitrni Lekarstvi|May 1, 1996
[Treatment of multiple myeloma]R Hájek, I Vásová, Z Adam, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Vnitrni Lekarstvi|October 1, 1995
[Biological effects of allogenic leukocytes and leukocyte-depleted blood cell products]I Vásová, J Mayer
Acta Medica Austriaca|January 1, 1996
New approaches to management of multiple myelomaR Hájek, I Vásová, Z Adam, et al.
Vnitrni Lekarstvi|June 1, 1995
[Infections in patients with central venous systems for long-term venous access: pathogenesis, classification, diagnosis and therapy]R Hájek, D Burgetová, I Vásová, et al.
Acta Medica Austriaca|January 1, 1996
Evolution of multiple myeloma treatment from melphalan monotherapy to bone marrow transplantationR Hájek, Z Adam, I Vásová, et al.
Bone Marrow Transplantation|April 1, 1999
Ifosfamide and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphomaJ Mayer, Z Korístek, I Vásová, et al.
Vnitrni Lekarstvi|January 1, 1997
[A new purine analog in the treatment of hematologic malignancy. I. Fludarabine]I Vásová, M Penka, R Hájek, et al.
Vnitrni Lekarstvi|April 1, 1996
[Evaluation of the cardioprotective effect of bispiperazinedione ICRF-187 (Cardioxane) in patients treated with anthracyclines--an echocardiographic study]L Elbl, I Vásová, V Chaloupka, et al.
Vnitrni Lekarstvi|April 1, 1996
[Treatment of multiple myeloma--melphalan monotherapy after bone marrow transplantation]R Hájek, Z Adam, M Krejcí, et al.
Vnitrni Lekarstvi|November 21, 2007
[Chronic fatigue syndrome in cancer patients. Diagnostic and treatment options]F Jedlicka, L Elbl, I Vásová, et al.
Vnitrni Lekarstvi|May 1, 1996
[Treatment of multiple myeloma]R Hájek, I Vásová, Z Adam, et al.
Pageof 3